Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-07-10 11:55 am Sale | 13D | ALECTOR INC ALEC | ORBIMED ADVISORS LLC | 5,502,048 7% | -964,944 (-14.92%) | View |
2020-07-06 5:57 pm Purchase | 13D | FUSION PHARMACEUTICALS INC FUSN | ORBIMED ADVISORS LLC | 2,997,981 7.2% | 2,997,981 (New Position) | View |
2020-07-01 5:31 pm Unchanged | 13D | TELA BIO INC TELA | ORBIMED ADVISORS LLC | 3,058,267 21.2% | 0 (Unchanged) | View |
2020-06-29 6:27 pm Purchase | 13D | COMPASS THERAPEUTICS INC CMPX | ORBIMED ADVISORS LLC | 12,714,404 24.4% | 12,714,404 (New Position) | View |
2020-06-25 8:19 pm Purchase | 13D | REPARE THERAPEUTICS INC RPTX | ORBIMED ADVISORS LLC | 3,276,325 8.9% | 3,276,325 (New Position) | View |
2020-06-11 4:25 pm Sale | 13D | BELLUS HEALTH INC BLU | ORBIMED ADVISORS LLC | 3,954,800 6.6% | -988,616 (-20.00%) | View |
2020-06-04 4:58 pm Sale | 13D | ALECTOR INC ALEC | ORBIMED ADVISORS LLC | 6,466,992 8.2% | -1,395,400 (-17.75%) | View |
2020-05-26 4:40 pm Purchase | 13D | SCPHARMACEUTICALS INC SCPH | ORBIMED ADVISORS LLC | 4,797,148 17.9% | 1,387,283 (+40.68%) | View |
2020-05-22 4:54 pm Sale | 13D | ASCENDIS PHARMA A/S SPONSORED ASND | ORBIMED ADVISORS LLC | 2,083,713 4.3% | -435,069 (-17.27%) | View |
2020-05-22 4:54 pm Unchanged | 13D | TURNING PT THERAPEUTICS INC CO TPTX | ORBIMED ADVISORS LLC | 2,027,550 4.9% | 0 (Unchanged) | View |
2020-05-20 4:54 pm Purchase | 13D | XTANT MED HLDGS INC XTNT | ORBIMED ADVISORS LLC | 14,014,321 77.7% | 2,400,000 (+20.66%) | View |
2020-05-07 9:48 pm Sale | 13D | ASCENDIS PHARMA A/S SPONSORED ASND | ORBIMED ADVISORS LLC | 2,518,782 5.2% | -493,118 (-16.37%) | View |
2020-05-01 4:15 pm Purchase | 13D | ORIC PHARMACEUTICALS INC ORIC | ORBIMED ADVISORS LLC | 2,765,717 9.2% | 2,765,717 (New Position) | View |
2020-04-17 4:13 pm Purchase | 13D | CORVUS PHARMACEUTICALS INC CRVS | ORBIMED ADVISORS LLC | 6,767,584 24.2% | 142,656 (+2.15%) | View |
2020-04-17 4:07 pm Purchase | 13D | KEROS THERAPEUTICS INC KROS | ORBIMED ADVISORS LLC | 1,268,734 6.3% | 1,268,734 (New Position) | View |
2020-04-16 8:15 pm Sale | 13D | ALECTOR INC ALEC | ORBIMED ADVISORS LLC | 7,862,392 10% | -853,952 (-9.80%) | View |
2020-03-27 1:47 pm Unchanged | 13D | SCPHARMACEUTICALS INC SCPH | ORBIMED ADVISORS LLC | 3,409,865 16.3% | 0 (Unchanged) | View |
2020-03-20 5:08 pm Purchase | 13D | IMARA INC IMRA | ORBIMED ADVISORS LLC | 2,532,402 15.3% | 2,532,402 (New Position) | View |
2020-03-10 5:03 pm Purchase | 13G | CTI BIOPHARMA CORP CTIC | ORBIMED ADVISORS LLC | 9,520,000 12.9% | 4,520,000 (+90.40%) | View |
2020-03-09 4:53 pm Purchase | 13D | PASSAGE BIO INC PASG | ORBIMED ADVISORS LLC | 5,947,323 13.5% | 5,947,323 (New Position) | View |